skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

This important white paper provides an analysis of kinase inhibitor trials for the management of rheumatoid arthritis, which have been discontinued and why, and which hold promise for easing the symptoms of this chronically progressive disease.

Highlights in this white paper include:

  • Phase II to III kinase inhibitor trials in RA initiated since mid-2010
  • Kinase inhibitors in active late stage development for RA
  • Kinase inhibitors discontinued for RA, and why
  • Trial sponsors who are having the greatest success and more

 

 

 

July-2015_Kinese-Inhibitors-in-RA_Gunilla-Sturrock

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: